Articles by Larissa Ku
China raw egg brand Yellow Swan raises $95m - update
Yellow Swan, a China-based edible raw egg producer incubated by Proterra Investment Partners, has raised CNY 600m (USD 95m) across two tranches.
China IPOs: Offshore angst
Private equity exit timelines were thrown into disarray last year when US IPOs abruptly stopped. Regulators have offered some clarity, but investors are unsure when – or if – the magic will return
China medtech start-up SiBionics raises $79m
China-based medical technology start-up SiBionics has raised CNY 500m (USD 79m) in a third tranche of Series C funding co-led by CPE and China Life Investment.
Vision Fund leads $150m round for China e-commerce enabler
Shoplazza, a China-based software-as-a-service (SaaS) provider specialising in cross-border e-commerce, has raised USD 150m in the first tranche of Series C led by SoftBank Vision Fund II.
River Head Capital hits first close on latest reminbi fund
China’s River Head Capital has achieved a first close on its second Innovation Growth Fund, a renminbi-denominated vehicle that has an overall target of CNY 2bn (USD 135m).
China beauty retailer Harmay raises $200m
Harmay, a China-based omnichannel beauty products retailer, has raised USD 200m across Series C and D rounds.
China's Dishangtie Car Rental raises $200m
Dishangtie Car Rental, a Shenzhen-based electric vehicle (EV) rental service, has raised a USD 200m Series D round across two tranches featuring CICC Capital.
Deal focus: Starfield serves up Series B
The Chinese manufacturer of plant-based protein replacements has secured USD 100m in funding to advance a product portfolio that aspires to diversity and structural sophistication
Q&A: Gulf Capital's Richard Dallas & Shantanu Mukerji
Richard Dallas, a senior managing director at Gulf Capital, and newly appointed Asia head Shantanu Mukerji on using Singapore as a regional hub, cross-border expansion, and why a dedicated regional fund is unlikely
China GPs emphasize consumer sector opportunities
Policy volatility in China has prompted many investors to eschew consumer-facing business models in favour of B2B plays like deep-tech, but sector specialists still see opportunity, the Hong Kong Venture Capital & Private Equity Association’s (HKVCA)...
China 5G chip designer Eigencomm raises $157m
SoftBank Vision Fund II has led a CNY 1bn (USD 157m) Series C for Shanghai-based chipmaker Eigencomm, with participation from new investors Cathay Capital, CoStone Capital, Chobe Capital, and GF Qianhe, a unit of GF Securities.
China plant-based protein player Starfield raises $100m
Primavera Capital Group has led a USD 100m Series B for Starfield, a Chinese producer of plant-based meats.
China sustainability start-up Bluepha raises $235m
Bluepha, a China-based synthetic biology company working on a range of biodegradable plastics, has raised a three-tranche Series B of CNY 1.5bn (USD 235m).
Fund focus: Eastern Bell targets digitalisation
As a supply chain specialist, Eastern Bell Capital claims to have a differentiated take on China industrial digitalisation. It has USD 800m in dry powder to prove this thesis
Sun Hung Kai leads Series B for Singapore digital asset bank
Sygnum, a Singapore and Switzerland-based digital asset bank, has raised a Series B of USD 90m - at a post-money valuation of USD 800m - led by Hong Kong-based investor Sun Hung Kai & Co.
China gene therapy start-up Cure Genetics raises $60m
Advantech Capital has led a USD 60m Series B for Suzhou-based biotech player Cure Genetics. Other investors include Oriza Holdings, Blue Ocean Private Equity, and Qiming Venture Partners.
China's Linear Capital raises $500m
Linear Capital, a China-based, technology-focused investment firm, has raised USD 500m for its fifth US dollar-denominated fund and its second opportunity Fund. It brings the firm’s total assets under management to USD 2bn.
China AI gaming company Parametrix raises $100m
Chinese artificial intelligence (AI) gaming company Parametrix.ai has raised a USD 100m Series B round led by Sequoia Capital China. Existing investors 5Y Capital and Gaorong Capital re-upped.
China CDMO Thousand Oaks raises $240m
Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization (CDMO), has raised CNY 1.5bn (USD 240m) in funding led by Goldstone Investment - a private equity unit of CITIC Securities - and CDH Investments.
Eastern Bell raises $2b across US dollar, renminbi funds
Eastern Bell Capital has closed its second US dollar-denominated fund and its sixth renminbi-denominated fund with aggregate commitments of more than CNY 13bn (USD 2bn).
2022 preview: China sustainability
Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022
2022 preview: China fundraising
Investors held fire on commitments to China managers amid uncertainty over regulatory reforms. Industry participants hope the government will provide clarity, but the fear LPs won’t hurry back
China supermarket chain T11 raises $100m
T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.
Q&A: Legend Capital's Richard Li
Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits